Ramesh J Chougule, associate vice president of the life sciences industry unit at global IT firm Infosys, talks about how big data is shaping the pharmaceutical industry.
For pharmaceutical businesses the past decade has been marked by turbulence and upheaval. The boom days when ‘blockbuster’ drugs earned their creators untold billions are now long past; the most lucrative patents have expired or are expiring. And in an industry where just one failed R&D project has the power to rock a company to…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
